Cargando…

Lipoprotein(a)—The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation

Increased lipoprotein(a) (Lp(a)) levels are an independent predictor of coronary artery disease (CAD), degenerative aortic stenosis (DAS), and heart failure independent of CAD and DAS. Lp(a) levels are genetically determinated in an autosomal dominant mode, with great intra- and inter-ethnic diversi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ugovšek, Sabina, Šebeštjen, Miran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773759/ https://www.ncbi.nlm.nih.gov/pubmed/35053174 http://dx.doi.org/10.3390/biom12010026

Ejemplares similares

Non-Lipid Effects of PCSK9 Monoclonal Antibodies on Vessel Wall
por: Ugovšek, Sabina, et al.
Publicado: (2022)

Influence of lipid-lowering drugs on inflammation: what is yet to be done?
por: Ugovšek, Sabina, et al.
Publicado: (2021)

Atherosclerotic Cardiovascular Disease: Risk Assessment, Prevention and Treatment Strategies
por: Jeras, Jernej, et al.
Publicado: (2022)

Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis
por: Chu, Chih-Sheng, et al.
Publicado: (2020)

Neutrophil Extracellular Traps and NLRP3 Inflammasome: A Disturbing Duo in Atherosclerosis, Inflammation and Atherothrombosis
por: Singh, Puneetpal, et al.
Publicado: (2023)

TNF-α Predicts Endothelial Function and Number of CD34(+) Cells after Stimulation with G-CSF in Patients with Advanced Heart Failure
por: Ugovšek, Sabina, et al.
Publicado: (2022)

The Role of Monocytes and Macrophages in Human Atherosclerosis, Plaque Neoangiogenesis, and Atherothrombosis
por: Moroni, Francesco, et al.
Publicado: (2019)

Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging
por: Barbu, Elena, et al.
Publicado: (2022)

Gene Expression Profiling of Markers of Inflammation, Angiogenesis, Coagulation and Fibrinolysis in Patients with Coronary Artery Disease with Very High Lipoprotein(a) Levels Treated with PCSK9 Inhibitors
por: Hrovat, Katja, et al.
Publicado: (2022)

Smoking and diabetes attenuate beneficial effects of PSCK9 inhibitors on arterial wall properties in patients with very high lipoprotein (a) levels
por: Rehberger Likozar, Andreja, et al.
Publicado: (2022)

Epidemiological Aspects of Atherosclerosis in Patients Treated for Acute Atherothrombosis of Extremity Arteries
por: Rustempasic, Nedzad, et al.
Publicado: (2014)

LPA Genotypes and Haplotypes Are Associated with Lipoprotein(a) Levels but Not Arterial Wall Properties in Stable Post-Coronary Event Patients with Very High Lipoprotein(a) Levels
por: Rehberger Likozar, Andreja, et al.
Publicado: (2021)

Cell Stress Proteins in Atherothrombosis
por: Madrigal-Matute, Julio, et al.
Publicado: (2012)

Predictors of functional and morphological arterial wall properties in coronary artery disease patients with increased lipoprotein (a) levels before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors
por: Likozar, Andreja Rehberger, et al.
Publicado: (2023)

Platelet thrombin receptor antagonism and atherothrombosis
por: Angiolillo, Dominick J., et al.
Publicado: (2010)

Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis
por: Suades, Rosa, et al.
Publicado: (2022)

Review of Prasugrel for the Secondary Prevention of Atherothrombosis
por: Spinler, Sarah A., et al.
Publicado: (2009)

Lipoprotein (a), Inflammation, and Atherosclerosis
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis
por: Badimon, Lina, et al.
Publicado: (2016)

PCSK9 Biology and Its Role in Atherothrombosis
por: Barale, Cristina, et al.
Publicado: (2021)

Mechanisms of atherothrombosis in chronic obstructive pulmonary disease
por: Fimognari, Filippo Luca, et al.
Publicado: (2008)

Association between Intestinal Microecological Changes and Atherothrombosis
por: Zhuo, Xinyu, et al.
Publicado: (2023)

The Contribution of Vascular Proteoglycans to Atherothrombosis: Clinical Implications
por: Drysdale, Amelia, et al.
Publicado: (2023)

Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis
por: Kasahara, Kazuyuki, et al.
Publicado: (2017)

Blood coagulation and the risk of atherothrombosis: a complex relationship
por: Spronk, Henri MH, et al.
Publicado: (2004)

Atherothrombosis: Pathogenesis of Cardiovascular Disease
por: Mojca, Stegnar
Publicado: (2003)

Platelet-Derived Exosomes and Atherothrombosis
por: Wei, Kangkang, et al.
Publicado: (2022)

PCSK9 as an Atherothrombotic Risk Factor
por: Sotler, Tadeja, et al.
Publicado: (2023)

Atherothrombosis is a Thrombotic, not Inflammatory Disease
por: Sloop, Gregory D, et al.
Publicado: (2017)

Macrophages at the Crossroad of Meta-Inflammation and Inflammaging
por: Qu, Lili, et al.
Publicado: (2022)

C-Reactive Protein in Atherothrombosis and Angiogenesis
por: Badimon, Lina, et al.
Publicado: (2018)

Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets
por: Martin-Ventura, Jose Luis, et al.
Publicado: (2017)

Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis
por: Di Pasquale, Elisa, et al.
Publicado: (2019)

Immune Response at the Crossroads of Atherosclerosis and Alzheimer's Disease
por: Stahr, Natalie, et al.
Publicado: (2022)

Osteopontin at the Crossroads of Inflammation and Tumor Progression
por: Castello, Luigi Mario, et al.
Publicado: (2017)

At the Crossroads of Inflammation and Tumorigenesis
por: Cordon-Cardo, Carlos, et al.
Publicado: (1999)

Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells
por: Anfossi, Giovanni, et al.
Publicado: (2010)

Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques
por: Asada, Yujiro, et al.
Publicado: (2020)

Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection
por: Otamas, Anastasia, et al.
Publicado: (2020)

Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease
por: Violi, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ojg33pc2l04pnkhhr731qvd6es